Alterity Therapeutics (ATHE) Depreciation & Amortization - Total (2014 - 2015)
Alterity Therapeutics' (ATHE) quarterly Depreciation & Amortization - Total came in at -$18372.2 in Q4 2015, up 36.45% year-on-year from -$13464.6 in Q4 2014, and up 36.45% quarter-over-quarter from -$28909.5 in Q4 2014.
Alterity Therapeutics (ATHE) Depreciation & Amortization - Total (2014 - 2015) Analysis & Trends
Alterity Therapeutics' Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at -$18372.2 for Q4 2015.
- On a quarterly basis, Depreciation & Amortization - Total rose 36.45% year-over-year to -$18372.2 in Q4 2015; TTM through Jun 2017 was -$18372.2, a 61.14% increase from a year earlier, with the FY2015 full-year figure at $26454.1, up 228.71% from the prior year.
- Depreciation & Amortization - Total grew to -$18372.2 in Q4 2015 per ATHE's latest filing, from -$28909.5 in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at -$18372.2 in Q4 2015 and bottomed at -$28909.5 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -18,372.25 |
| Dec 31, 2014 | -28,909.45 |